Last edition
News about "Priya Singhal"
Biogen Closes Acquisition of RayThera
Biogen completes the acquisition of RayThera Inc., adding a phase 1 lead program to strengthen its pipeline and advance innovative therapeutic development.
Priya Singhal | 07/08/2026 | By News Bureau
Biogen Announces Topline Phase 2 Results for Diranersen in Early Alzheimer's Disease
Ionis partner Biogen announces topline phase 2 CELIA trial results for diranersen (BIIB080), showing reduced tau pathology and cognitive benefits in patients with early Alzheimer's Disease (AD).
Priya Singhal | 15/05/2026 | By News Bureau | 163
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy